Grow Everything Biotech Podcast

Messaginglab

Grow Everything explores the world of biology as technology. Hosts Erum Khan and Karl Schmieder interview leaders and influencers biologizing industries with tools like synthetic biology, precision fermentation, bioprospecting, and more. These companies make biomaterials from waste, cosmetics that restore healthy hair and skin, and delicious cultivated foods in a bioreactor and so much more. Join us as we discuss the latest and greatest across biotech, engineered biology, entrepreneurship, and culture and how this transition is solving healthcare and climate change challenges.

  1. 1d ago

    208. Sow Much Potential: Hunter Lovins Rewrites Climate Economics with Natural Capitalism

    What if protecting nature were central to building a stronger business? In this episode of Grow Everything, Erum Azeez Khan and Karl Schmieder speak with Hunter Lovins, president of Natural Capitalism Solutions and a steward of COPx, about the economic case for valuing ecosystems and creating an economy that serves life. Hunter explains how regenerative agriculture can build healthier soil and more resilient food systems, why businesses should look to nature for design principles, and how community action can complement global climate negotiations. She also discusses LanzaTech’s approach to turning emissions into useful products, the importance of ecological guardrails for bioinnovators, and why patient capital matters when biological solutions take time to develop. The hosts also discuss biotech news, biomimetics and the upcoming Genspace fundraiser. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and speak with the leaders and innovators using biology to change the world. Biology is the world’s oldest technology, and it can be engineered. So, what are we growing? Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.messaginglab.com/groweverything⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Chapters: (00:00:00) - Welcome to Grow Everything and Cuba’s biotech industry(00:06:00) - Amyris and Oobli, biotech news and industry disputes(00:13:00) - Meet Hunter Lovins and the case for natural capitalism(00:20:00) - Interface and the business case for valuing nature(00:27:00) - Regenerative business and nature’s design principles(00:34:00) - Regenerative agriculture, soil health and food resilience(00:41:00) - COP climate negotiations and community action(00:48:00) - Biomimicry, biodiversity and regenerative economies(00:55:00) - Waste to value, biotech innovation and patient capital(01:02:00) - Hunter’s quick fire answers and episode takeawaysLinks and Resources: Hunter LovinsCOPxNatural Capitalism SolutionsA Finer Future by Hunter LovinsNatural Capitalism by Hunter LovinsBiomatter Raises $18M Series A to Scale its AI-Powered Enzyme Design for Global Industry LeadersAmyris, Inc. to acquire industry-leading sweet protein innovator OobliScientist stole trade secrets from startup that wants to bring back extinct species: bombshell suitBiomimetics International69. Stress Less and Impress: Matereal's Jackie Amable Announces Million-Fold Safer Textile Coating64. Swaying Away from Plastics: Julia Marsh's Seaweed Solutions43. Emission Impossible: Lanzatech’s Zara Summers on Converting Carbon into CashGrow Everything LinkedInGenspace Fundraiser for Giving Tuesday - Fundraiser goes live 12/01Topics Covered: regenerative agriculture, natural capitalism, COPX, climate action, ecosystem services, regenerative economy, soil carbon sequestration, bioinnovation, waste-to-value Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠Grow Everything⁠⁠⁠⁠⁠⁠⁠⁠ Music by: Nihilore Production by: Amplafy Media

  2. Nov 13

    207. Bio-Made in the USA: Jill Zullo Builds Domestic Scale at BioMADE

    What does it take to turn a promising biological discovery into a product made at industrial scale? In this episode of Grow Everything, Erum Azeez Khan speaks with Jill Zullo, executive vice president and chief operating officer of BioMADE, about the infrastructure, economics and partnerships needed to bring biomanufacturing out of the lab. Drawing on her experience at Cargill and NatureWorks, Jill explains why organisms must withstand changing conditions in larger fermenters, how purification and trace impurities can make or break a process, and why teams should model costs, mass and energy before entering a pilot plant. They explore BioMADE’s pilot plant network in California, Iowa and Minnesota, community college training, the role of government demand, and how shared facilities could help more biological products reach the market. Karl Schmieder and Erum also discuss the week in biotech and the upcoming Genspace fundraiser. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and speak with the leaders and innovators using biology to change the world. Biology is the world’s oldest technology, and it can be engineered. So, what are we growing? Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.messaginglab.com/groweverything⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Chapters: (00:00:00) - Biotech news and a conversation with BioMADE’s Jill Zullo(00:07:00) - One person biotech companies and engineered working dogs(00:14:00) - NSF X Labs funding and the Genspace fundraiser(00:20:00) - BioMADE, supply chain security and rural jobs(00:26:00) - Fermentation scale up, purification and process economics(00:32:00) - BioMADE pilot plants and biomanufacturing workforce training(00:38:00) - BioMADE partnerships, drop ins and customer demand(00:45:00) - Biomanufacturing policy and government procurement(00:51:00) - Shared facilities, distributed manufacturing and rapid fire(00:58:00) - Biomanufacturing commercialization takeaways Links and Resources: BioMADEJill Zullo LinkedInBioMADE Pilot Plant NetworkBioMADE at UC Davis114. BioMADE in America: Crafting the Future of Biomanufacturing with CEO Doug Friedman96. Brewing Medicines with Synthetic Biology: Antheia's Christina Smolke on Ending Drug Shortages183. The American Biotech Blueprint: Senator Todd Young on Biodiversity as National SecurityTechnology Innovation Institute Launches Cutting-Edge Biofoundry to Advance R&D in Synthetic BiologyAnthropic acquires Mithril, a one person biotech companyDallas Startup Warhound Raises $200M to Genetically Engineer and Clone Elite Military DogsNSF X-Labs Biofunding opportunity Grow everything LinkedIn Genspace: Giving Tuesday Fundraiser Topics Covered: BioMADE, biomanufacturing, domestic biomanufacturing, biomanufacturing scale-up, pilot plant network, fermentation scale-up, downstream processing, techno-economic analysis, biomanufacturing workforce development, bioeconomy Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠Grow Everything⁠⁠⁠⁠⁠⁠⁠⁠ Music by: Nihilore Production by: Amplafy Media

  3. Nov 6

    206. No Longer Lost in Translation: Anna Marie & Renee Decode the Bench at Transfyr

    Why do promising discoveries sometimes get stuck between the lab bench and the real world? In this episode of Grow Everything, hosts Erum Azeez Khan and Karl Schmieder speak with Transfer AI cofounders Anne Marie Wagner and Renee Wegrzyn about the hidden steps that make scientific experiments difficult to reproduce and transfer. Drawing on their experience at Ginkgo Bioworks, DARPA and the Advanced Research Projects Agency for Health, they explain how cameras, environmental sensors and AI can capture the practical knowledge scientists rarely write down, helping teams understand which variations matter. The conversation explores reproducibility, technology transfer, investment risk, scientific creativity and a future where better data helps researchers bring discoveries to patients and the bioeconomy. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and speak with the leaders and innovators using biology to change the world. Biology is the world’s oldest technology, and it can be engineered. So, what are we growing? Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.messaginglab.com/groweverything⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Chapters: (00:00:00) - AI drug discovery and the pace of biological research(00:07:00) - Meet Transfer AI cofounders Anne Marie Wagner and Renee Wegrzyn(00:14:00) - Why scientific protocols miss the details that matter(00:21:00) - How physical AI observes scientists without disrupting their work(00:28:00) - From lab observations to reproducible experiments and technology transfer(00:35:00) - Why physical execution is a biotech bottleneck(00:42:00) - Cofounder leadership and solving real customer pain(00:49:00) - Investor diligence and protecting teams from distractions(00:56:00) - Magic hands, rapid fire questions and the future of science(01:03:00) - What’s next on Grow EverythingLinks and Resources: Transyr AIRenee Wegrzyn Anna Marie WagnerTransfyr Launches Physical AI Platform for Science with $25M Seed FundingHow a former ARPA-H director’s startup is tackling AI’s ‘dumb problems’OpenAI, PerturbAI⁠, and Scripps Research used thousands of AI agents with GPT‑Rosalind to analyze existing experimental data in just 32 minutes35. Unlocking the Gene-ius of AI-Powered Biology: Teselagen's Eduardo Abeliuk 172. Generating Needles in Haystacks: Elise de Reus Designs Proteins with Cradle2. The Biotech Century with Megan PalmerGrow everything LinkedInTopics Covered: physical AI for science, AI in biology labs, lab reproducibility, scientific knowledge transfer, biotech tech transfer, lab automation, experimental protocol optimization, AI-powered lab monitoring, biomanufacturing scale-up, scientific data capture Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠Grow Everything⁠⁠⁠⁠⁠⁠⁠⁠ Music by: Nihilore Production by: Amplafy Media

  4. Oct 30

    205. The Sweet Taste of Negative Waste: Max Kufner Ferments Carbon Waste at Again

    What does it take to turn industrial carbon dioxide into useful chemicals at a price the market will accept? On Grow Everything, Karl Schmieder and Erum Azeez Khan speak with Max Kufner, cofounder and CEO of Again, about using gas fermentation to make acetate and other products from industrial emissions. Max explains why feedstock economics and locating production close to customers matter, what the acquisition of Genomatica brings to Again, and why real production data is essential for predicting whether a bioprocess can work at industrial scale. He also shares how customer demand, licensing, project finance, and partnerships can help move biotechnology from the lab into the real world. Before the interview, the hosts explore an AI assisted biomanufacturing class and the latest discussion around deextinction. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and speak with the leaders and innovators using biology to change the world. Biology is the world’s oldest technology, and it can be engineered. So, what are we growing? Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.messaginglab.com/groweverything Chapters: (00:00:00) - Biology, public engagement, and biomanufacturing education(00:05:00) - AI agents and cell free protein experiments(00:10:00) - Deextinction, the moa, and biotechnology(00:15:00) - Max Kufner on turning carbon dioxide into chemicals(00:20:00) - From venture capital to building Again(00:26:00) - Industrial bioreactors and manufacturing at the source(00:32:00) - Financing biotechnology scale with customer partnerships(00:38:00) - Building biomanufacturing facilities in the US and Europe(00:44:00) - Climate tech quick fire: engineers, finance, and teamwork(00:50:00) - Founder takeaways: customer demand and cost parityLinks and Resources: Again Bio.Max Kufner LinkedInStartup, Again: Turning CO₂ Emissions into Carbon-negative ChemicalsAgain acquires Geno to combine AI-driven discovery with industrial biomanufacturingColossal, who de-extincted the dire wolf, now hatches chicks from artificial egg to help de-extinct moa113. Microbe Mission Possible: Noah Helman Discusses iMicrobes' Quest to Turn Waste into Wealth170. There's a Bug for That: Sophia Xu on CarbonBridge's Notebook Bioreactors102. Waste into WOW! Cemvita's Moji Karimi on Turning Carbon Problems into Golden OpportunitiesGrow everything LinkedIn Topics Covered: biomanufacturing, AI x bio, climate tech, green chemicals, sustainable manufacturing, industrial biotechnology, biotech scale-up, deep tech financing, carbon-negative products, alternative chemicals Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠Grow Everything⁠⁠⁠⁠⁠⁠⁠⁠ Music by: Nihilore Production by: Amplafy Media

  5. Oct 23

    204. Moore's Law Than Meets the Eye: Michael Wright's Blueprint at Biomimetics International

    Michael Wright, founder of Biomimetics International, joins Grow Everything to explain how learning from nature can reshape the way we design products, build businesses, and scale emerging industries. Drawing on decades in semiconductors and high technology, he describes biomimetics as learning from nature’s tested systems, from burr inspired Velcro to shark skin that reduces drag, while emphasizing that copying a biological function is not enough if a product cannot return safely to the biosphere. He introduces the Biosverse, nature’s third number, and generational cost of ownership as ways to account for environmental liabilities that traditional business models may overlook. The conversation explores how digital and biological systems converge, why biotech can learn from semiconductor standards and roadmaps, how AI might benefit from a more nurturing and accountable design approach, and why leaders should ask, “Do you know what you do does?” Michael’s vision is a mindset shift that brings nature into the design process before we build, then measures whether innovations can serve communities and remain compatible with the living world. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and speak with the leaders and innovators using biology to change the world. Biology is the world’s oldest technology, and it can be engineered. So, what are we growing? Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.messaginglab.com/groweverything⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Chapters: (00:00:00) Grow Everything opening and biotech headlines, from fall foliage to food systems for Mars(00:07:00) FDA inspections, peptide manufacturing, and the importance of knowing where products come from(00:14:00) Michael Wright’s semiconductor career and the path to biomimetics(00:21:00) How digital and biological systems converge, from precision agriculture to digital water(00:28:00) The Biosverse, biosphere compatibility, and nature’s third number(00:35:00) Generational impact, executive decisions, and long term costs(00:42:00) What biotech can learn from semiconductor roadmaps, standards, and shared infrastructure(00:49:00) AI as a mom, biological sensing, and symbiotic decision making(00:56:00) Michael’s dream project: a mindset shift toward looking at nature first(01:03:00) Quick fire questions, the episode debrief, and designing data centers with nature in mindEpisode Links: Biomimetics InternationalMichael WrightThe Exponential Era by David Espindola and Michael WrightNASA Mars to Table ChallengeFall foliage tracker in NYBlack mold, bugs found at Chinese plants making GLP-1 compounding agentsCemvita and Roebling Partner to Accelerate Industrial BioSolutions From Discovery to Deployment199. Space, the Final Fermenter: Mario Maggio Brews Biology in Orbit with Ambrosia Space156. When Matter Makes Decisions: Michael Levin on the Intelligence of Form133. Funding, Frameworks & Frenemies: Dr. Angela Belcher of NSCEB Gets Real on the $15B Biotech Boost Plan71. Squid Pro Quo: Tandem Repeat's Melik Demirel Reinvents Clothing with SquitexGrow everything LinkedIn Topics Covered: biomimetics, bio-inspired design, biosphere compatibility, generational cost of ownership, nature-inspired materials, biomimicry in engineering, sustainable data centers, AI and biomimicry, biomimetics industry standards, circular materials Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠⁠Grow Everything⁠⁠⁠⁠⁠⁠⁠⁠⁠ Music by: Nihilore Production by: Amplafy Media

  6. Oct 16

    203. The Valley of Do: Karl & Erum Orchestrate Bio-Ecosystems at Bioinnovations Conference

    At Bio Innovations in Omaha and an adjacent investor gathering in Houston, Grow Everything hosts Karl Schmieder and Erum Azeez Khan unpack the shift reshaping the bioeconomy: scientific discovery is becoming faster and less expensive, while deployment, scale up, and durable partnerships have become the real competitive advantage. They share conversations from the conference floor on the missing middle between bench science and commercial production, the Midwest’s feedstock and infrastructure advantage, the need for early technoeconomic discipline, and how corporates can give innovators clearer demand and specification targets. From pilot facilities and downstream processing to waste to value opportunities and resilient domestic supply chains, this recap maps the practical work required to turn biological innovation into products that matter. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and speak with the leaders and innovators using biology to change the world. Biology is the world’s oldest technology, and it can be engineered. So, what are we growing? Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.messaginglab.com/groweverything⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Chapters: (00:00:00) Halloween, food dyes, and a motel room microbiology discovery(00:05:29) The fire microbe and the promise of extremophiles for manufacturing(00:07:46) AI agents, scientific discovery, and physical laboratories(00:14:43) Bio Innovations recap: Omaha infrastructure meets Houston capital(00:18:00) Discovery is cheaper, but deployment is the whole game(00:22:24) The missing middle: pilots, ecosystems, and the valley of do(00:26:45) Business models, corporate demand clarity, and consumer framing(00:34:40) Scale up lessons: feasibility, downstream processing, and tech transfer(00:42:28) Waste to value, bioeconomic resilience, and what comes nextLinks and Resources: BioinnovationsSteve Bray - TritenIAGPhillip Crawford -RoeblingMike Glasspool - MerrickKyle Pomraning - Pacific Northwest National LabGatorade recall across 37 states in the U.S.Scientist discovered two new species of bacteria from a motel room they converted into a labIncendiamoeba cascadensis. This 'fire amoeba' pushes the limit of what's possible for complex lifeClaude discovers a novel enzyme system with CRISPR-like repeatsC5R Built a Research Lab Run by AI in 12 Weeks.164. From Plasmids to Pallets: How Erin Marasco Scales Biology at Cargill165. Biology Behind the Brands: Inside P&G’s Two-Century Story166. The Great Reformulation: Joshua Lachter Rethinks How We Make Everything at Scale102. Waste into WOW! Cemvita's Moji Karimi on Turning Carbon Problems into Golden Opportunities Topics Covered: autonomous labs, laboratory robotics, AI in biotechnology, synthetic biology, bioengineering, biological automation, data as a service, biotech infrastructure, cell engineering, programmable biology Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠Grow Everything⁠⁠⁠⁠⁠⁠⁠⁠ Music by: Nihilore  Production by: Amplafy Media

  7. Oct 9

    202. Setting Sail for Biotech Scale: Jenny Rooke Steers Innovators at Genoa Venture

    Genoa Ventures founder and managing director Jenny Rooke joins Karl Schmieder and Erum Azeez to explore bioconvergence, the expanding frontier where biology meets AI, automation, materials science, and real world business building. Drawing on her journey from physics and genetics to venture capital, Jenny explains why durable bio based companies must pair novel science with clear customer demand, disciplined scale up, and a path to meaningful commercial value. The conversation examines lessons from early synthetic biology, the realities of biomanufacturing at scale, next generation clinical assessment tools, and why founders working between traditional tech and biotech categories need investors who understand both. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and speak with the leaders and innovators using biology to change the world. Biology is the world’s oldest technology, and it can be engineered. So, what are we growing? Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.messaginglab.com/groweverything⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Chapters: (00:00:00) Climate Week, bioliteracy, and biology as a climate solution(00:03:00) America’s Living Library Act and the case for sampling public lands(00:07:00) State microbes, public engagement, and the future of bioliteracy(00:10:00) Erum’s biomanufacturing course and designing food safe colors(00:15:00) Introducing Jenny Rooke and Genoa Ventures(00:17:00) From physics and genetics to investing in science based companies(00:20:00) The Genoa sail: founder autonomy, trust, and avoiding fatal mistakes(00:22:00) What defines a bioconvergence company(00:24:00) Why biotechnology needs a broader frame than pharma(00:26:00) Lessons from synthetic biology’s first wave and the impact of AI(00:28:00) Matching company timelines to biology, markets, and venture returns(00:29:00) The future of clinical assessment tools and actionable health data(00:32:00) Diagnostics, consumer data, and the difference between insight and infotainment(00:34:00) Why bio based businesses can offer investors a different risk profile(00:37:00) Why industrial biotechnology companies fail and what scale up requires(00:40:00) Biomanufacturing, commercial readiness, and Genoa’s newest investment(00:42:00) What Genoa is watching across tools, biology, and manufacturing(00:45:00) Jenny’s four word credo and the founder mindset(00:48:00) Closing reflections on bioconvergence and building the bioeconomyLinks and Resources: Genoa VenturesJenny Rooke LinkedInGenoa Ventures LinkedInJPM 2026: Genoa Ventures’ Jenny Rooke on Next-Gen Clinical Assessment ToolsGraveyard report - First Bite Ventures3 States Have Official State Microbes National Security Commission of Emerging BiotechTopics Covered: bioconvergence, deep tech venture capital, synthetic biology investing, biomanufacturing, life science tools, clinical diagnostics, industrial biotech, bioeconomy Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠Grow Everything⁠⁠⁠⁠⁠⁠⁠⁠ Music by: Nihilore  Production by: Amplafy Media

  8. Oct 2

    201. Out of Cell Experience: Michael Heltzen Drives Pure Chemistry at eXoZymes

    Michael Heltzen, CEO of Exozymes, joins Grow Everything to explain how cell free biomanufacturing is opening new possibilities for natural products, nutraceuticals, and medicines. Michael shares why engineered enzymes can make high purity molecules without relying on living cells, how Exozymes moved its NCT program from discovery toward commercial manufacturing in less than two years, and why its capital light partnership model is central to scaling impact. The conversation also explores AI guided enzyme design, digital twins for manufacturing, rare cannabinoids, downstream processing, and the disciplined focus required to turn a broad biotechnology platform into real products. Grow Everything brings the bioeconomy to life. Hosts Karl Schmieder and Erum Azeez Khan share stories and speak with the leaders and innovators using biology to change the world. Biology is the world’s oldest technology, and it can be engineered. So, what are we growing? Learn more at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.messaginglab.com/groweverything⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Chapters: (00:00:00) Michael Heltzen and the Exozymes mission(00:05:00) Why cell free manufacturing can unlock inaccessible natural products(00:10:00) Combining molecular biology, computation, and AI guided enzyme design(00:15:00) From laboratory platform to industrial scale production(00:20:00) Commercial partnerships and the NCT market opportunity(00:25:00) Rare cannabinoids and a new toolkit for medicinal chemistry(00:30:00) The capital light licensing model for biomanufacturing(00:35:00) Downstream processing, purity, and investor skepticism(00:40:00) The future of sustainable enzyme driven chemical manufacturing(00:45:00) Key takeaways on focus, partnerships, and platform innovationLinks and Resources: eXoZymes⁠eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery⁠eXoZymes’ Cell-Free Biomanufacturing Platform Gets Positive Feedback from Cayman Chemical⁠Michael Heltzen LinkedIn⁠eXoZymes on LinkedIn⁠129. No Cells? No Problem! eXoZymes' Michael Heltzen on the Future of Microbe-Free Biotech176. Dare to Commercialize: Damien Perriman’s eXoZymes Playbook51. Cell-Free, Problem-Free: Enzyme Alchemy with Alex Rosay at Cascade Biocatalysts85. Always Be Brewing: Continuous Fermentation with Cauldron's Michele StansfieldTopics Covered: cell-free biomanufacturing, enzyme engineering, exozymes, biosynthesis, cannabinoids, NCT (N-trans-caffeoyltyramine), synthetic biology, AI-driven enzyme design, scalable bioproduction, sustainable chemicals Have a question or comment? Message us here: Text or Call (804) 505-5553 ⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠Youtube⁠⁠⁠⁠⁠⁠⁠⁠ / ⁠⁠⁠⁠⁠⁠⁠⁠Grow Everything⁠⁠⁠⁠⁠⁠⁠⁠ Music by: Nihilore  Production by: Amplafy Media

4.9
out of 5
22 Ratings

About

Grow Everything explores the world of biology as technology. Hosts Erum Khan and Karl Schmieder interview leaders and influencers biologizing industries with tools like synthetic biology, precision fermentation, bioprospecting, and more. These companies make biomaterials from waste, cosmetics that restore healthy hair and skin, and delicious cultivated foods in a bioreactor and so much more. Join us as we discuss the latest and greatest across biotech, engineered biology, entrepreneurship, and culture and how this transition is solving healthcare and climate change challenges.

You Might Also Like